The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure. 

The 59-year-old cardiologist was known for both his clinical knowledge and his warm personality. He practiced with the same city hospital for nearly three decades. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Heart teams already have access to several augmented reality and virtual reality offerings, and many more are on the way.

Which modality should care teams choose for PCI guidance? While there's an argument to be made for choosing IVUS over OCT, some specialists think the two treatment options are close to equal in terms of patient outcomes. 

According to Oregon Heart Center, an independent cardiology practice, Salem Health is attempting to "monopolize cardiology care" in the area. The two providers had previously coexisted for years. 

LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.

Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.

The funds, including a significant investment from Johnson & Johnson, are expected to go toward expanding access to the company's HyperVue Imaging System and exploring new features.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

The current evidence suggests early surgery is a better treatment option for asymptomatic severe AS than conservative care, researchers explained.